Thousands of U.S. health agency employees were terminated and told it was for poor performance, though they'd received strong ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...

U.S. approves conditional use of avian influenza vaccine amid spreading outbreak U.S. greenlights temporary use of bird flu ...

The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

For tech companies, the healthcare vertical is now the fastest growing business. The US, which spends about $5 trillion on ...

A chemical engineering professor at the University of Cincinnati is developing new ways to deliver treatments for infectious ...

The Senate has voted to confirm the nomination of Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Publicly traded ...

The World Health Organization wants to tackle inequity and bureaucracy relating to clinical trials. Will its latest guidance make a difference? Anna Volkmer reports During the covid-19 pandemic the UK ...

Trump administration to eliminate thousands of federal health jobs; Major drugmakers plan to meet with Trump; New York versus Louisiana abortion pills fight.

Pfizer shows profit growth from cost cuts and ... The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts ...